About
Technology
Issues
FAQ
Links
Official Page
SAMHD1 is a biomarker for cytarabine response and a therapeutic target in acute myeloid leukemia
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.